These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

500 related items for PubMed ID: 28420068

  • 1. Pentraxin-3 levels are associated with vasculitis and disease activity in childhood-onset systemic lupus erythematosus.
    Sahin S, Adrovic A, Barut K, Durmus S, Gelisgen R, Uzun H, Kasapcopur O.
    Lupus; 2017 Sep; 26(10):1089-1094. PubMed ID: 28420068
    [Abstract] [Full Text] [Related]

  • 2. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P, Hrycek A.
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [Abstract] [Full Text] [Related]

  • 3. Pentraxin 3 is associated with disease activity but not atherosclerosis in patients with systemic lupus erythematosus.
    Shimada Y, Asanuma YF, Yokota K, Yoshida Y, Kajiyama H, Sato K, Akiyama Y, Mimura T.
    Mod Rheumatol; 2014 Jan; 24(1):78-85. PubMed ID: 24261762
    [Abstract] [Full Text] [Related]

  • 4. Initial digital vasculitis in a large multicenter cohort of childhood-onset systemic lupus erythematosus.
    Sakamoto AP, Silva CA, Silva MFCD, Lopes AS, Russo GCS, Sallum AME, Kozu K, Bonfá E, Saad-Magalhães C, Pereira RMR, Len CA, Terreri MT.
    Rev Bras Reumatol Engl Ed; 2017 Jan; 57(6):583-589. PubMed ID: 29050884
    [Abstract] [Full Text] [Related]

  • 5. PTX3 in small-vessel vasculitides: an independent indicator of disease activity produced at sites of inflammation.
    Fazzini F, Peri G, Doni A, Dell'Antonio G, Dal Cin E, Bozzolo E, D'Auria F, Praderio L, Ciboddo G, Sabbadini MG, Manfredi AA, Mantovani A, Querini PR.
    Arthritis Rheum; 2001 Dec; 44(12):2841-50. PubMed ID: 11762945
    [Abstract] [Full Text] [Related]

  • 6. Interferon-α coincides with suppressed levels of pentraxin-3 (PTX3) in systemic lupus erythematosus and regulates leucocyte PTX3 in vitro.
    Wirestam L, Enocsson H, Skogh T, Eloranta ML, Rönnblom L, Sjöwall C, Wetterö J.
    Clin Exp Immunol; 2017 Jul; 189(1):83-91. PubMed ID: 28257596
    [Abstract] [Full Text] [Related]

  • 7. Prevalence and clinical significance of anti-ribosomal P antibody in childhood-onset systemic lupus erythematosus.
    Aldar H, Lapa AT, Bellini B, Sinicato NA, Postal M, Fernandes PT, Costallat LT, Marini R, Appenzeller S.
    Lupus; 2012 Oct; 21(11):1225-31. PubMed ID: 22740428
    [Abstract] [Full Text] [Related]

  • 8. Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
    Yuan M, Tan Y, Pang Y, Li YZ, Song Y, Yu F, Zhao MH.
    Ren Fail; 2017 Nov; 39(1):465-473. PubMed ID: 28393653
    [Abstract] [Full Text] [Related]

  • 9. Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
    Joo YB, Park SY, Won S, Bae SC.
    J Rheumatol; 2016 Aug; 43(8):1490-7. PubMed ID: 27252431
    [Abstract] [Full Text] [Related]

  • 10. Serum pentraxin 3 in systemic lupus erythematosus: A potential indicator of cutaneous disease activity.
    Ismail SA, Awad SM, Gamal RM, Gaber MA, Hussein SM, Hammam N.
    Lupus; 2023 Jun; 32(7):873-879. PubMed ID: 37183233
    [Abstract] [Full Text] [Related]

  • 11. PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
    Ramirez GA, Rovere-Querini P, Blasi M, Sartorelli S, Di Chio MC, Baldini M, De Lorenzo R, Bozzolo EP, Leone R, Mantovani A, Manfredi AA, Tombetti E.
    Front Immunol; 2019 Jun; 10():1135. PubMed ID: 31191526
    [Abstract] [Full Text] [Related]

  • 12. Circulating pentraxin-3 levels in patients with systemic lupus erythematosus: a meta-analysis.
    Wu Q, Guan SY, Dan YL, Zhao CN, Mao YM, Liu LN, Li XM, Wang DG, Pan HF.
    Biomark Med; 2019 Nov; 13(16):1417-1427. PubMed ID: 31599644
    [Abstract] [Full Text] [Related]

  • 13. A Multicenter Study of Invasive Fungal Infections in Patients with Childhood-onset Systemic Lupus Erythematosus.
    Silva MF, Ferriani MP, Terreri MT, Pereira RM, Magalhães CS, Bonfá E, Campos LM, Okuda EM, Appenzeller S, Ferriani VP, Barbosa CM, Ramos VC, Lotufo S, Silva CA.
    J Rheumatol; 2015 Dec; 42(12):2296-303. PubMed ID: 26568586
    [Abstract] [Full Text] [Related]

  • 14. IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus.
    Bassi N, Ghirardello A, Blank M, Zampieri S, Sarzi-Puttini P, Mantovani A, Shoenfeld Y, Doria A.
    Ann Rheum Dis; 2010 Sep; 69(9):1704-10. PubMed ID: 20439287
    [Abstract] [Full Text] [Related]

  • 15. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
    Amezcua-Guerra LM, Springall R, Arrieta-Alvarado AA, Rodríguez V, Rivera-Martinez E, Castillo-Martinez D, Bojalil R.
    Clin Lab; 2011 Sep; 57(7-8):607-13. PubMed ID: 21888025
    [Abstract] [Full Text] [Related]

  • 16. Childhood-onset systemic lupus erythematosus in Singapore: clinical phenotypes, disease activity, damage, and autoantibody profiles.
    Tan JH, Hoh SF, Win MT, Chan YH, Das L, Arkachaisri T.
    Lupus; 2015 Aug; 24(9):998-1005. PubMed ID: 25926055
    [Abstract] [Full Text] [Related]

  • 17. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J, Kopeć W, Jakobsche-Policht U, Adamiec R.
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [Abstract] [Full Text] [Related]

  • 18. Cytokine profile in childhood-onset systemic lupus erythematosus: a cross-sectional and longitudinal study.
    Cavalcanti A, Santos R, Mesquita Z, Duarte AL, Lucena-Silva N.
    Braz J Med Biol Res; 2017 Apr 03; 50(4):e5738. PubMed ID: 28380214
    [Abstract] [Full Text] [Related]

  • 19. Vasculitis in systemic lupus erythematosus (SLE)--assessment of peripheral blood mononuclear cell activation and the degree of endothelial dysfunction: initial report.
    Kluz J, Kopeć W, Jakobsche U, Prajs I, Adamiec R.
    Postepy Hig Med Dosw (Online); 2007 Dec 03; 61():725-35. PubMed ID: 18063917
    [Abstract] [Full Text] [Related]

  • 20. S100β is associated with cognitive impairment in childhood-onset systemic lupus erythematosus patients.
    Lapa AT, Postal M, Sinicato NA, Bellini BS, Fernandes PT, Marini R, Appenzeller S.
    Lupus; 2017 Apr 03; 26(5):478-483. PubMed ID: 28394234
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.